Inspirata Acquires Digital Pathology Company Omnyx, Enabling Delivery of an IVD Device for Primary Diagnosis in Europe and Canada
Inspirata to reignite Dynamyx® software platform, ensuring commitments to existing customers while positioning the business for global expansion
Tampa, FL, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it has acquired Pittsburgh, PA-based Omnyx from GE Healthcare.
Omnyx was an early innovator in bringing brilliant software to pathology departments around the world. The company's flagship digital pathology software product, Dynamyx(TM), enhances the pathology workflow by providing new channels for collaboration and tools to boost efficiency. Combined with Inspirata's solution-as-a service approach, Dynamyx eases adoption challenges and empowers pathologists. The software is CE-marked in Europe and licensed by Health Canada for in vitro diagnostic (IVD) use.
"The acquisition of Omnyx positions Inspirata with the most comprehensive digital pathology workflow solution in the world," says Inspirata CEO Satish Sanan. "It brings us the last mile to reach our goal of having an end-to-end integrated pathology solution with a scanner-agnostic whole slide image viewer and image management system. It also gives us a fully supported IVD device cleared for primary digital diagnosis in Europe and Canada, and it expands our customer base and geographic footprint across those countries."
Inspirata plans to retain Omnyx' office and its employees. The company will use this location and the resources to create a center of excellence for ongoing digital pathology software development. "Our short-term plan is to rapidly combine the advantages of our digital pathology software platform and the Dynamyx platform by converging them onto a shared, state-of-the-art technology stack," continues Sanan.
"Inspirata has shown a strong commitment to promoting the adoption of digital pathology to improve cancer diagnostics," says Omnyx CEO Andrew Chomos. "By combining our platforms, we will be able to offer a device and application agnostic solution in both Europe and Canada that can integrate with pathology departments' existing hardware and health information systems."
About Inspirata, Inc.
Inspirata®, Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis today. The solution, which employs a unique "solution-as-a-service" business and delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data cancer repository for clinical, research and educational purposes. Its use will extend to physicians, patients, researchers and pharma among others. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit www.inspirata.com or contact firstname.lastname@example.org.
About Omnyx, LLC
Omnyx®, LLC, a digital pathology venture of GE Healthcare, has helped transform the way pathologists worldwide work and collaborate. Through its Precision Solution(TM) that includes the brilliant Dynamyx® software and transformative consulting, all members of the cancer care team can work together to enhance patient outcomes. Dynamyx goes beyond simple image viewing and evaluation. It streamlines case management and communication among the entire care team while providing a foundation for image analysis algorithms to enable pathologists to gain deeper insights into patients' cancers. The open platform features bi-directional enterprise connectivity, which helps to eliminate manual tasks and reduce errors. The Omnyx vision is a world in which efficient and effective cancer diagnosis helps guide personalized patient care. Omnyx products are for in vitro diagnostic use for specific clinical applications and are intended for research use only on other applications.
All trademarks used herein are the property of their respective owners.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/b58aa542-73ef-4061-8c40-5389f7746f03
Marjorie Bulone Inspirata, Inc. 813-570-8905 email@example.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Inspirata, Inc. via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
Mandalay Resources går ut med måldatum för publicering av resultatet för det fjärde kvartalet och hela 2017 samt konferenssamtal19.2.2018 03:42 | Pressmeddelande
TORONTO, 16 februari 2018 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation ("Mandalay" eller "Bolaget") (TSX:MND) meddelade idag att resultaten från det fjärde kvartalet och hela 2017 kommer att släppas efter att marknaden stängt den 21 februari 2018. Detta efterföljs av ett konferenssamtal för investerare och analytiker med Mandalays President och Chief Executive Officer, Mark Sander, den 22 februari 2018 klockan 08:00 (Toronto-tid). Analytiker och investerare inbjuds att delta med följande uppringningsnummer: Deltagarnummer: (201) 689-8341 Deltagarnummer (avgiftsfritt): (877) 407-8289 Konferens-ID: 13676606 En repris av konferenssamtalet kommer att finnas tillgänglig fram till den 8 mars 2018 klockan 23:59 (Toronto-tid), vilken man kommer åt med följande uppringningsnummer: Encore avgiftsfritt uppringningsnummer: (877) 660-6853 Encore-ID: 13676606 För mer information: Mark Sander President och Chief Executive Officer Greg DiTomaso Director of Investor Relations Kontakt: +1.647.260.
Standard Lithium Announces Closing of $21.6 million Bought Deal Private Placement of Units16.2.2018 19:25 | Pressmeddelande
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSX-V:SLL) (OTCQX:STLHF) (FRA:S5L) announced today that it has closed its previously announced bought deal private placement of 10,312,821 units of the Company (the "Units"), at a price of $2.10 per Unit, for aggregate gross proceeds to the Company of $21,656,924, including the issuance and sale of the Underwriters' (as defined below) option (the "Offering"). Each Unit consists of one common share of the Company and one-half of one common share purchase warrant (each whole common share purchase warrant, a "Warrant"). Each Warrant is exercisable to acquire one common share of the Company (a "Warrant Share") until February 16, 2020 at an exercise price of $2.60 per Warrant Share, subject to adjus
Cisco Offers Cloud-Based Endpoint Security Solutions for Managed Security Service Providers16.2.2018 14:00 | Pressmeddelande
Cisco's comprehensive cloud-based security endpoint portfolio provides advanced malware protection, internet security, and enterprise mobility management SAN JOSE, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Cisco today is helping address the challenges of Managed Security Service Providers (MSSP) and their customers by offering MSSPs comprehensive security, visibility, and control of customer endpoints without added hardware or complexity. The Cisco endpoint security portfolio includes three industry-leading solutions-Cisco AMP for Endpoints, Cisco Umbrella, and Meraki Systems Manager to offer protection against advanced malware and threats. Security teams know the endpoints in their environments are being targeted by advanced threats, but often lack the security talent, tools, and budget to address those challenges. As a result, organizations of all sizes are choosing to augment their in-house IT security with managed security services. Nearly half of SMBs and enterprises in the US1 ar
Aurora Solar Adds Heterojunction Cell Characterization to Decima Gemini Family16.2.2018 14:00 | Pressmeddelande
Aurora Solar Technologies Inc. / Aurora Solar Adds Heterojunction Cell Characterization to Decima Gemini Family . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. NORTH VANCOUVER, British Columbia, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Aurora Solar Technologies Inc. ("Aurora") ("Company") (TSX.V:ACU) (OTCBB:AACTF) (FSE:A82) is pleased to provide an update on the further development of its Decima Gemini(TM) infrared measurement technology for applications in the rapidly developing heterojunction (HJT) cell manufacturing market. HJT is an ultra high-efficiency solar cell design pioneered by Japan's Panasonic Corp., who is now also partnered with Tesla Inc. for solar products. According to Solar Media Ltd., HJT production capacity is expected to increase by 20 percent this year. To produce the electrical structure of a HJT cell, it is necessary to apply thin layers of amorphous silicon on both sides of a crystallin
Nasdaq Cited as a Leader in Governance, Risk, and Compliance Platforms by Independent Research Firm16.2.2018 13:35 | Pressmeddelande
NEW YORK, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) was among the select companies that Forrester invited to participate in its 2018 Forrester Wave(TM) evaluation, Governance, Risk, And Compliance (GRC) Platforms, Q1 2018. In this evaluation, Nasdaq was cited as a Leader in Governance, Risk, and Compliance Platforms and received the maximum score of 5 for the evaluation criteria "Risk & Control Management", "Audit Management", "Dashboard and Reporting" and "Integration capabilities" for its BWise solutions. "We feel the strong scores we obtained in important functional areas provide assurance to our clients that they have selected a robust and future-proof software platform," said Tom Passon, Head of Product Innovation & Global Standards, Nasdaq BWise. "We are proud of this recognition that encourages us to further execute on our strategy to provide user-friendly, pre-configured best practice solutions that combine our innovative GRC software platform with leading expertis
Mandalay Resources Provides Target Release Date for Fourth Quarter and Full-Year 2017 Financial Results and Conference Call16.2.2018 13:30 | Pressmeddelande
TORONTO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation ("Mandalay" or "the Company") (TSX:MND) today announced that its fourth quarter and full-year 2017 financial results will be released after market close on February 21, 2018, followed by a conference call with Mark Sander, President and Chief Executive Officer of Mandalay, for investors and analysts on February 22, 2018 at 8:00 am (Toronto time). Analysts and interested investors are invited to participate using the following dial-in numbers: Participant Number: (201) 689-8341 Participant Number (Toll free): (877) 407-8289 Conference ID: 13676606 A replay of the conference call will be available until 11:59 pm (Toronto time), March 8, 2018 and can be accessed using the following dial-in number: Encore Toll Free Dial-in Number: (877) 660-6853 Encore ID: 13676606 For Further Information: Mark Sander President and Chief Executive Officer Greg DiTomaso Director of Investor Relations Contact: +1.647.260.1566 About Man
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum